A generic drug is a pharmaceutical drug that is equivalent to a brand-name product in dosage, strength, route of administration, quality, performance, and intended use. The term may also refer to any drug marketed under its chemical name without advertising, or to the chemical makeup of a drug rather than the brand name under which the drug is sold.
This report aims to provide a comprehensive presentation of the global market for Generic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Drugs. This report contains market size and forecasts of Generic Drugs in global, including the following market information:
Global Generic Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Generic Drugs market was valued at US$ 322540 million in 2022 and is projected to reach US$ 550750 million by 2029, at a CAGR of 7.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Market competition is not intense. Teva, Novartis ? Sandoz, Mylan, Sun Pharmaceutical and Aspen are the leaders of the industry, with about 19% market shares.
North America is the largest consumption place, with a consumption market share nearly 44%. Following North America, Europe is the second largest consumption place with the consumption market share of 18%.
We surveyed the Generic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Generic Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Generic Drugs Market Segment Percentages, by Type, 2022 (%)
Prescription
Non-Prescription Drugs
Global Generic Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Generic Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Generic Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Generic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Generic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Generic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Teva
Novartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma
Pharmaniaga Berhad
Hovid Berhad
Duopharma Biotech
Kotra Pharma
HOE Pharmaceutical
Y.S.P. Industries
Outline of Major Chapters:
Chapter 1: Introduces the definition of Generic Drugs, market overview.
Chapter 2: Global Generic Drugs market size in revenue.
Chapter 3: Detailed analysis of Generic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Generic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Generic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Generic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Generic Drugs Overall Market Size
2.1 Global Generic Drugs Market Size: 2022 VS 2029
2.2 Global Generic Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Generic Drugs Players in Global Market
3.2 Top Global Generic Drugs Companies Ranked by Revenue
3.3 Global Generic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Generic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Generic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Generic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Generic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Generic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Generic Drugs Market Size Markets, 2022 & 2029
4.1.2 Prescription
4.1.3 Non-Prescription Drugs
4.2 By Type - Global Generic Drugs Revenue & Forecasts
4.2.1 By Type - Global Generic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Generic Drugs Revenue, 2024-2029
4.2.3 By Type - Global Generic Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Generic Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Generic Drugs Revenue & Forecasts
5.2.1 By Application - Global Generic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Generic Drugs Revenue, 2024-2029
5.2.3 By Application - Global Generic Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Generic Drugs Market Size, 2022 & 2029
6.2 By Region - Global Generic Drugs Revenue & Forecasts
6.2.1 By Region - Global Generic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Generic Drugs Revenue, 2024-2029
6.2.3 By Region - Global Generic Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Generic Drugs Revenue, 2018-2029
6.3.2 US Generic Drugs Market Size, 2018-2029
6.3.3 Canada Generic Drugs Market Size, 2018-2029
6.3.4 Mexico Generic Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Generic Drugs Revenue, 2018-2029
6.4.2 Germany Generic Drugs Market Size, 2018-2029
6.4.3 France Generic Drugs Market Size, 2018-2029
6.4.4 U.K. Generic Drugs Market Size, 2018-2029
6.4.5 Italy Generic Drugs Market Size, 2018-2029
6.4.6 Russia Generic Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Generic Drugs Market Size, 2018-2029
6.4.8 Benelux Generic Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Generic Drugs Revenue, 2018-2029
6.5.2 China Generic Drugs Market Size, 2018-2029
6.5.3 Japan Generic Drugs Market Size, 2018-2029
6.5.4 South Korea Generic Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Generic Drugs Market Size, 2018-2029
6.5.6 India Generic Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Generic Drugs Revenue, 2018-2029
6.6.2 Brazil Generic Drugs Market Size, 2018-2029
6.6.3 Argentina Generic Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Generic Drugs Revenue, 2018-2029
6.7.2 Turkey Generic Drugs Market Size, 2018-2029
6.7.3 Israel Generic Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Generic Drugs Market Size, 2018-2029
6.7.5 UAE Generic Drugs Market Size, 2018-2029
7 Generic Drugs Companies Profiles
7.1 Teva
7.1.1 Teva Company Summary
7.1.2 Teva Business Overview
7.1.3 Teva Generic Drugs Major Product Offerings
7.1.4 Teva Generic Drugs Revenue in Global Market (2018-2023)
7.1.5 Teva Key News & Latest Developments
7.2 Novartis - Sandoz
7.2.1 Novartis - Sandoz Company Summary
7.2.2 Novartis - Sandoz Business Overview
7.2.3 Novartis - Sandoz Generic Drugs Major Product Offerings
7.2.4 Novartis - Sandoz Generic Drugs Revenue in Global Market (2018-2023)
7.2.5 Novartis - Sandoz Key News & Latest Developments
7.3 Mylan
7.3.1 Mylan Company Summary
7.3.2 Mylan Business Overview
7.3.3 Mylan Generic Drugs Major Product Offerings
7.3.4 Mylan Generic Drugs Revenue in Global Market (2018-2023)
7.3.5 Mylan Key News & Latest Developments
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Company Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Generic Drugs Major Product Offerings
7.4.4 Sun Pharmaceutical Generic Drugs Revenue in Global Market (2018-2023)
7.4.5 Sun Pharmaceutical Key News & Latest Developments
7.5 Aspen
7.5.1 Aspen Company Summary
7.5.2 Aspen Business Overview
7.5.3 Aspen Generic Drugs Major Product Offerings
7.5.4 Aspen Generic Drugs Revenue in Global Market (2018-2023)
7.5.5 Aspen Key News & Latest Developments
7.6 Fresenius Kabi
7.6.1 Fresenius Kabi Company Summary
7.6.2 Fresenius Kabi Business Overview
7.6.3 Fresenius Kabi Generic Drugs Major Product Offerings
7.6.4 Fresenius Kabi Generic Drugs Revenue in Global Market (2018-2023)
7.6.5 Fresenius Kabi Key News & Latest Developments
7.7 Pfizer (Hospira)
7.7.1 Pfizer (Hospira) Company Summary
7.7.2 Pfizer (Hospira) Business Overview
7.7.3 Pfizer (Hospira) Generic Drugs Major Product Offerings
7.7.4 Pfizer (Hospira) Generic Drugs Revenue in Global Market (2018-2023)
7.7.5 Pfizer (Hospira) Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Generic Drugs Major Product Offerings
7.8.4 Sanofi Generic Drugs Revenue in Global Market (2018-2023)
7.8.5 Sanofi Key News & Latest Developments
7.9 Aurobindo
7.9.1 Aurobindo Company Summary
7.9.2 Aurobindo Business Overview
7.9.3 Aurobindo Generic Drugs Major Product Offerings
7.9.4 Aurobindo Generic Drugs Revenue in Global Market (2018-2023)
7.9.5 Aurobindo Key News & Latest Developments
7.10 Lupin
7.10.1 Lupin Company Summary
7.10.2 Lupin Business Overview
7.10.3 Lupin Generic Drugs Major Product Offerings
7.10.4 Lupin Generic Drugs Revenue in Global Market (2018-2023)
7.10.5 Lupin Key News & Latest Developments
7.11 Dr. Reddy's
7.11.1 Dr. Reddy's Company Summary
7.11.2 Dr. Reddy's Business Overview
7.11.3 Dr. Reddy's Generic Drugs Major Product Offerings
7.11.4 Dr. Reddy's Generic Drugs Revenue in Global Market (2018-2023)
7.11.5 Dr. Reddy's Key News & Latest Developments
7.12 Apotex
7.12.1 Apotex Company Summary
7.12.2 Apotex Business Overview
7.12.3 Apotex Generic Drugs Major Product Offerings
7.12.4 Apotex Generic Drugs Revenue in Global Market (2018-2023)
7.12.5 Apotex Key News & Latest Developments
7.13 Cipla
7.13.1 Cipla Company Summary
7.13.2 Cipla Business Overview
7.13.3 Cipla Generic Drugs Major Product Offerings
7.13.4 Cipla Generic Drugs Revenue in Global Market (2018-2023)
7.13.5 Cipla Key News & Latest Developments
7.14 ENDO (Par Pharmaceutical)
7.14.1 ENDO (Par Pharmaceutical) Company Summary
7.14.2 ENDO (Par Pharmaceutical) Business Overview
7.14.3 ENDO (Par Pharmaceutical) Generic Drugs Major Product Offerings
7.14.4 ENDO (Par Pharmaceutical) Generic Drugs Revenue in Global Market (2018-2023)
7.14.5 ENDO (Par Pharmaceutical) Key News & Latest Developments
7.15 Stada Arzneimittel
7.15.1 Stada Arzneimittel Company Summary
7.15.2 Stada Arzneimittel Business Overview
7.15.3 Stada Arzneimittel Generic Drugs Major Product Offerings
7.15.4 Stada Arzneimittel Generic Drugs Revenue in Global Market (2018-2023)
7.15.5 Stada Arzneimittel Key News & Latest Developments
7.16 Krka Group
7.16.1 Krka Group Company Summary
7.16.2 Krka Group Business Overview
7.16.3 Krka Group Generic Drugs Major Product Offerings
7.16.4 Krka Group Generic Drugs Revenue in Global Market (2018-2023)
7.16.5 Krka Group Key News & Latest Developments
7.17 Nichi-Iko Pharmaceutical
7.17.1 Nichi-Iko Pharmaceutical Company Summary
7.17.2 Nichi-Iko Pharmaceutical Business Overview
7.17.3 Nichi-Iko Pharmaceutical Generic Drugs Major Product Offerings
7.17.4 Nichi-Iko Pharmaceutical Generic Drugs Revenue in Global Market (2018-2023)
7.17.5 Nichi-Iko Pharmaceutical Key News & Latest Developments
7.18 Valeant
7.18.1 Valeant Company Summary
7.18.2 Valeant Business Overview
7.18.3 Valeant Generic Drugs Major Product Offerings
7.18.4 Valeant Generic Drugs Revenue in Global Market (2018-2023)
7.18.5 Valeant Key News & Latest Developments
7.19 Zydus Cadila
7.19.1 Zydus Cadila Company Summary
7.19.2 Zydus Cadila Business Overview
7.19.3 Zydus Cadila Generic Drugs Major Product Offerings
7.19.4 Zydus Cadila Generic Drugs Revenue in Global Market (2018-2023)
7.19.5 Zydus Cadila Key News & Latest Developments
7.20 Hikma
7.20.1 Hikma Company Summary
7.20.2 Hikma Business Overview
7.20.3 Hikma Generic Drugs Major Product Offerings
7.20.4 Hikma Generic Drugs Revenue in Global Market (2018-2023)
7.20.5 Hikma Key News & Latest Developments
7.21 Pharmaniaga Berhad
7.21.1 Pharmaniaga Berhad Company Summary
7.21.2 Pharmaniaga Berhad Business Overview
7.21.3 Pharmaniaga Berhad Generic Drugs Major Product Offerings
7.21.4 Pharmaniaga Berhad Generic Drugs Revenue in Global Market (2018-2023)
7.21.5 Pharmaniaga Berhad Key News & Latest Developments
7.22 Hovid Berhad
7.22.1 Hovid Berhad Company Summary
7.22.2 Hovid Berhad Business Overview
7.22.3 Hovid Berhad Generic Drugs Major Product Offerings
7.22.4 Hovid Berhad Generic Drugs Revenue in Global Market (2018-2023)
7.22.5 Hovid Berhad Key News & Latest Developments
7.23 Duopharma Biotech
7.23.1 Duopharma Biotech Company Summary
7.23.2 Duopharma Biotech Business Overview
7.23.3 Duopharma Biotech Generic Drugs Major Product Offerings
7.23.4 Duopharma Biotech Generic Drugs Revenue in Global Market (2018-2023)
7.23.5 Duopharma Biotech Key News & Latest Developments
7.24 Kotra Pharma
7.24.1 Kotra Pharma Company Summary
7.24.2 Kotra Pharma Business Overview
7.24.3 Kotra Pharma Generic Drugs Major Product Offerings
7.24.4 Kotra Pharma Generic Drugs Revenue in Global Market (2018-2023)
7.24.5 Kotra Pharma Key News & Latest Developments
7.25 HOE Pharmaceutical
7.25.1 HOE Pharmaceutical Company Summary
7.25.2 HOE Pharmaceutical Business Overview
7.25.3 HOE Pharmaceutical Generic Drugs Major Product Offerings
7.25.4 HOE Pharmaceutical Generic Drugs Revenue in Global Market (2018-2023)
7.25.5 HOE Pharmaceutical Key News & Latest Developments
7.26 Y.S.P. Industries
7.26.1 Y.S.P. Industries Company Summary
7.26.2 Y.S.P. Industries Business Overview
7.26.3 Y.S.P. Industries Generic Drugs Major Product Offerings
7.26.4 Y.S.P. Industries Generic Drugs Revenue in Global Market (2018-2023)
7.26.5 Y.S.P. Industries Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Generic Drugs Market Opportunities & Trends in Global Market
Table 2. Generic Drugs Market Drivers in Global Market
Table 3. Generic Drugs Market Restraints in Global Market
Table 4. Key Players of Generic Drugs in Global Market
Table 5. Top Generic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Generic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Generic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Generic Drugs Product Type
Table 9. List of Global Tier 1 Generic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Generic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Generic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Generic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Generic Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Generic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Generic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Generic Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Generic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Generic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Generic Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Generic Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Generic Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Generic Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Generic Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Generic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Generic Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Teva Company Summary
Table 31. Teva Generic Drugs Product Offerings
Table 32. Teva Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Teva Key News & Latest Developments
Table 34. Novartis - Sandoz Company Summary
Table 35. Novartis - Sandoz Generic Drugs Product Offerings
Table 36. Novartis - Sandoz Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis - Sandoz Key News & Latest Developments
Table 38. Mylan Company Summary
Table 39. Mylan Generic Drugs Product Offerings
Table 40. Mylan Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Mylan Key News & Latest Developments
Table 42. Sun Pharmaceutical Company Summary
Table 43. Sun Pharmaceutical Generic Drugs Product Offerings
Table 44. Sun Pharmaceutical Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Sun Pharmaceutical Key News & Latest Developments
Table 46. Aspen Company Summary
Table 47. Aspen Generic Drugs Product Offerings
Table 48. Aspen Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Aspen Key News & Latest Developments
Table 50. Fresenius Kabi Company Summary
Table 51. Fresenius Kabi Generic Drugs Product Offerings
Table 52. Fresenius Kabi Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Fresenius Kabi Key News & Latest Developments
Table 54. Pfizer (Hospira) Company Summary
Table 55. Pfizer (Hospira) Generic Drugs Product Offerings
Table 56. Pfizer (Hospira) Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Pfizer (Hospira) Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Generic Drugs Product Offerings
Table 60. Sanofi Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Aurobindo Company Summary
Table 63. Aurobindo Generic Drugs Product Offerings
Table 64. Aurobindo Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Aurobindo Key News & Latest Developments
Table 66. Lupin Company Summary
Table 67. Lupin Generic Drugs Product Offerings
Table 68. Lupin Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Lupin Key News & Latest Developments
Table 70. Dr. Reddy's Company Summary
Table 71. Dr. Reddy's Generic Drugs Product Offerings
Table 72. Dr. Reddy's Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Dr. Reddy's Key News & Latest Developments
Table 74. Apotex Company Summary
Table 75. Apotex Generic Drugs Product Offerings
Table 76. Apotex Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Apotex Key News & Latest Developments
Table 78. Cipla Company Summary
Table 79. Cipla Generic Drugs Product Offerings
Table 80. Cipla Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Cipla Key News & Latest Developments
Table 82. ENDO (Par Pharmaceutical) Company Summary
Table 83. ENDO (Par Pharmaceutical) Generic Drugs Product Offerings
Table 84. ENDO (Par Pharmaceutical) Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. ENDO (Par Pharmaceutical) Key News & Latest Developments
Table 86. Stada Arzneimittel Company Summary
Table 87. Stada Arzneimittel Generic Drugs Product Offerings
Table 88. Stada Arzneimittel Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Stada Arzneimittel Key News & Latest Developments
Table 90. Krka Group Company Summary
Table 91. Krka Group Generic Drugs Product Offerings
Table 92. Krka Group Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 93. Krka Group Key News & Latest Developments
Table 94. Nichi-Iko Pharmaceutical Company Summary
Table 95. Nichi-Iko Pharmaceutical Generic Drugs Product Offerings
Table 96. Nichi-Iko Pharmaceutical Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 97. Nichi-Iko Pharmaceutical Key News & Latest Developments
Table 98. Valeant Company Summary
Table 99. Valeant Generic Drugs Product Offerings
Table 100. Valeant Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 101. Valeant Key News & Latest Developments
Table 102. Zydus Cadila Company Summary
Table 103. Zydus Cadila Generic Drugs Product Offerings
Table 104. Zydus Cadila Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 105. Zydus Cadila Key News & Latest Developments
Table 106. Hikma Company Summary
Table 107. Hikma Generic Drugs Product Offerings
Table 108. Hikma Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 109. Hikma Key News & Latest Developments
Table 110. Pharmaniaga Berhad Company Summary
Table 111. Pharmaniaga Berhad Generic Drugs Product Offerings
Table 112. Pharmaniaga Berhad Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 113. Pharmaniaga Berhad Key News & Latest Developments
Table 114. Hovid Berhad Company Summary
Table 115. Hovid Berhad Generic Drugs Product Offerings
Table 116. Hovid Berhad Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 117. Hovid Berhad Key News & Latest Developments
Table 118. Duopharma Biotech Company Summary
Table 119. Duopharma Biotech Generic Drugs Product Offerings
Table 120. Duopharma Biotech Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 121. Duopharma Biotech Key News & Latest Developments
Table 122. Kotra Pharma Company Summary
Table 123. Kotra Pharma Generic Drugs Product Offerings
Table 124. Kotra Pharma Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 125. Kotra Pharma Key News & Latest Developments
Table 126. HOE Pharmaceutical Company Summary
Table 127. HOE Pharmaceutical Generic Drugs Product Offerings
Table 128. HOE Pharmaceutical Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 129. HOE Pharmaceutical Key News & Latest Developments
Table 130. Y.S.P. Industries Company Summary
Table 131. Y.S.P. Industries Generic Drugs Product Offerings
Table 132. Y.S.P. Industries Generic Drugs Revenue (US$, Mn) & (2018-2023)
Table 133. Y.S.P. Industries Key News & Latest Developments
List of Figures
Figure 1. Generic Drugs Segment by Type in 2022
Figure 2. Generic Drugs Segment by Application in 2022
Figure 3. Global Generic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Generic Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Generic Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Generic Drugs Revenue in 2022
Figure 8. By Type - Global Generic Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Generic Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Generic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Generic Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Generic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Generic Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Generic Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Generic Drugs Revenue Market Share, 2018-2029
Figure 16. US Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Generic Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Generic Drugs Revenue Market Share, 2018-2029
Figure 28. China Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Generic Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Generic Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Generic Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Teva Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis - Sandoz Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Mylan Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sun Pharmaceutical Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Aspen Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Fresenius Kabi Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Pfizer (Hospira) Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sanofi Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Aurobindo Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Lupin Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Dr. Reddy's Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Apotex Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Cipla Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. ENDO (Par Pharmaceutical) Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Stada Arzneimittel Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Krka Group Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Nichi-Iko Pharmaceutical Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Valeant Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Zydus Cadila Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Hikma Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Pharmaniaga Berhad Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Hovid Berhad Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Duopharma Biotech Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Kotra Pharma Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. HOE Pharmaceutical Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 66. Y.S.P. Industries Generic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
